Land: USA
Språk: engelsk
Kilde: NLM (National Library of Medicine)
ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D), HYDROCODONE BITARTRATE (UNII: NO70W886KK) (HYDROCODONE - UNII:6YKS4Y3WQ7)
Atlantic Biologicals Corps
ACETAMINOPHEN
ACETAMINOPHEN 325 mg in 15 mL
ORAL
PRESCRIPTION DRUG
Hydrocodone bitartrate and acetaminophen oral solution is indicated for the relief of moderate to moderately severe pain. This product should not be administered to patients who have previously exhibited hypersensitivity to hydrocodone, acetaminophen, or any other component of this product. Patients known to be hypersensitive to other opioids may exhibit cross-sensitivity to hydrocodone. Hydrocodone bitartrate oral solution contains hydrocodone, an opioid agonist, and is a Schedule II controlled substance. Hydrocodone bitartrate oral solution, and other opioids used in analgesia can be abused and are subject to criminal diversion. Misuse Abuse and Diversion of Opioids Addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite ha
NDC:17856-0640-2 in a CUP, UNIT-DOSE of 15 SOLUTIONS Store at 20° - 25°C (68° - 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container with a child-resistant closure. Dispense the Patient Information Leaflet with the drug product. PHARMACIST: A Schedule CII Narcotic. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Manufactured for: a Subsidiary of Qualitest Pharmaceuticals Huntsville, AL 35811 1-800-444-4011 Rev. 09/2014 500309-01 Boca Pharmacal, LLC
Abbreviated New Drug Application
HYDROCODONE BITARTRATE AND ACETAMINOPHEN- HYDROCODONE BITARTRATE, ACETAMINOPHEN SOLUTION ATLANTIC BIOLOGICALS CORPS ---------- HYDROCODONE BITARTRATE AND ACETAMINOPHEN ORAL SOLUTION (7.5 MG/325 MG PER 15 ML) CII RX ONLY HEPATOTOXICITY Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4,000 milligrams per day, and often involve more than one acetaminophen-containing product. DESCRIPTION Hydrocodone bitartrate and acetaminophen is supplied in liquid form for oral administration. WARNING:MAY BE HABIT-FORMING (SEE , , AND ). PRECAUTIONSINFORMATION FOR PATIENTSDRUG ABUSE AND DEPENDENCE Hydrocodone bitartrate is an opioid analgesic and antitussive and occurs as fine, white crystals or as a crystalline powder. It is affected by light. The chemical name is 4,5α-epoxy-3-methoxy-17- methylmorphinan-6-one tartrate (1:1) hydrate (2:5). It has the following structural formula: Acetaminophen, 4’-hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non- opiate, non-salicylate analgesic and antipyretic. It has the following structural formula: Hydrocodone Bitartrate and Acetaminophen oral solution contains: Per 5 mL Per 15 mL Hydrocodone Bitartrate …………………………… 2.5 mg 7.5 mg WARNING: MAY BE HABIT-FORMING. Acetaminophen …………………………………… 108 mg 325 mg Alcohol ……………………………………………. 7% 7% In addition, the liquid contains the following inactive ingredients: citric acid anhydrous, ethyl maltol, glycerin, methylparaben, propylene glycol, propylparaben, purified water, saccharin sodium, sorbitol solution, sucrose, with D&C Red #33 and FD&C Red #40 as coloring and natural and artificial flavoring. CLINICAL PHARMACOLOGY Hydrocodone is a semisynthetic narcotic analgesic and antitussive with multiple actions qualitatively similar to those of codeine. Most of these inv Les hele dokumentet